HARVARD BIOSCIENCE, INC. Derivative, Fair Value, Net
HARVARD BIOSCIENCE, INC. (HBIO) had Derivative, Fair Value, Net of $223.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Notes › Derivative Instrument Detail
us-gaap:DerivativeFairValueOfDerivativeNet · last filed 2024-11-08
- 2024-09-30: Derivative, Fair Value, Net $223.00K.
- 2024-06-30: Derivative, Fair Value, Net $34.00K.
- 2023-12-31: Derivative, Fair Value, Net -$199.00K.
| Period end | Derivative, Fair Value, Net |
|---|---|
| 2024-09-30 | $223.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $34.00K 10-Q · filed 2024-08-08 |
| 2023-12-31 | -$199.00K 10-Q · filed 2024-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |